Scholar Rock Holding Corp (SRRK) Stock Analysis

Scholar Rock Holding Corp (SRRK) is a publicly traded company in the HEALTHCARE sector. It trades at $44.68, carries a market capitalization of $5.68B. This page summarizes the public market data, fundamentals, and frequently asked questions for SRRK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Scholar Rock Holding Corp currently has a Bullish sentiment score of 0.19.

About Scholar Rock Holding Corp

Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the development of targeted therapies for serious diseases influenced by protein growth factor signaling. Utilizing a pioneering approach to harness the therapeutic potential of the TGF-beta superfamily, Scholar Rock is advancing a promising pipeline that addresses critical conditions, including muscular dystrophy and various cancers. Committed to transform...

GNG Research Analysis

GNG Research scores Scholar Rock Holding Corp (SRRK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SRRK.

Frequently Asked Questions

Does SRRK pay dividends?

Scholar Rock Holding Corp (SRRK) does not currently pay a regular dividend.

What is SRRK's market cap?

Scholar Rock Holding Corp (SRRK) has a market capitalization of $5.68B with a current stock price of $44.68.